Literature DB >> 15706986

The expression of human antimicrobial peptide LL-37 in the human nasal mucosa.

Po-Hsu Chen1, Sheen-Yie Fang.   

Abstract

BACKGROUND: LL-37, an antimicrobial peptide, has been discovered to be produced by a number of epithelial cells. It is identified as a key element in the innate host defense mechanism. Because little is known about the expression of LL-37 in human sinonasal tract, we conducted this study to investigate the expression of LL-37 in human nasal mucosa.
METHODS: We investigated the expression of LL-37 gene by the reverse transcription polymerase chain reaction (RT-PCR) and localization of LL-37 peptide by immunohistochemistry in the inferior turbinate mucosa of 7 normal subjects and the nasal polyps of 12 patients with chronic paranasal sinusitis.
RESULTS: The transcripts of the LL-37 gene were detected in all human nasal tissues analyzed by RT-PCR. There is a significant increase of LL-37 mRNA expression in nasal polyps as compared with the normal nasal mucosa. Using immunohistochemistry, LL-37 peptide was localized in surface epithelial cells and submucosal glands.
CONCLUSIONS: Our findings suggest that LL-37 is expressed by nasal mucosa and is upregulated during inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15706986

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  10 in total

1.  Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps.

Authors:  Andrew P Lane; Quynh Ai Truong-Tran; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2006 Mar-Apr

2.  Role of C3a as a Novel Regulator of 25(OH)D3 to 1α,25-Dihydroxyvitamin D3 Metabolism in Upper Airway Epithelial Cells.

Authors:  Jennifer K Mulligan; Dianna Nord; Maria V Villanueva; Jeb Justice; Brian Lobo; Rodney J Schlosser; Carl Atkinson
Journal:  J Immunol       Date:  2022-07-06       Impact factor: 5.426

Review 3.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

4.  Assessment of epithelial innate antimicrobial factors in sinus tissue from patients with and without chronic rhinosinusitis.

Authors:  Jivianne T Lee; Oswaldo H Escobar; Rabin Anouseyan; Agnieszka Janisiewicz; Edward Eivers; Keith E Blackwell; David B Keschner; Rohit Garg; Edith Porter
Journal:  Int Forum Allergy Rhinol       Date:  2014-09-07       Impact factor: 3.858

5.  Topical cathelicidin (LL-37) an innate immune peptide induces acute olfactory epithelium inflammation in a mouse model.

Authors:  Jeremiah A Alt; Xuan Qin; Abigail Pulsipher; Quinn Orb; Richard R Orlandi; Jianxing Zhang; Austin Schults; Wanjian Jia; Angela P Presson; Glenn D Prestwich; Siam Oottamasathien
Journal:  Int Forum Allergy Rhinol       Date:  2015-09-08       Impact factor: 3.858

6.  Prevention of sinonasal inflammation by a synthetic glycosaminoglycan.

Authors:  Abigail Pulsipher; Xuan Qin; Andrew J Thomas; Glenn D Prestwich; Siam Oottamasathien; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2016-11-11       Impact factor: 3.858

7.  LL-37 causes cell death of human nasal epithelial cells, which is inhibited with a synthetic glycosaminoglycan.

Authors:  Andrew J Thomas; Abigail Pulsipher; Brock M Davis; Jeremiah A Alt
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

Review 8.  Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy.

Authors:  Fatai Lu; Yingkang Zhu; Guodong Zhang; Zunpeng Liu
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

9.  Significance of susceptible gene expression profiles in nasal polyposis.

Authors:  De Yun Wang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-12-26       Impact factor: 3.372

10.  The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease.

Authors:  Yanmei Li; Yanan Wang; Ying Liu; Yatian Wang; Xiuli Zuo; Yanqing Li; Xuefeng Lu
Journal:  Mediators Inflamm       Date:  2014-08-18       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.